Pfizer Inc: (NYSE: PFE)

$29.40

0.24 (0.82%)

Volume 159,805,408

Jun 18 04:00 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 29.03 - 29.45
52wk Low - High 22.00 - 31.15
Previous Close 29.16
Avg. Volume 67,159,736
Industry LARGE CAP PHARMA
Market Cap 206.84 B
Div - Yield 0.96 - 3.29
Beta 0.73
P/E (F1) 13.20
Current Year Est. 2.21
Quarterly Earnings ESP -3.57%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Rank Change Trend3

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Neutral

Zacks Industry Rank

178 out of 265

Equity Research Report

Updated as of 06/14/2013

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

P/E (F1) 13.20
PEG Ratio 3.16
Current Year Est. 2.21
Current Quarter Estimate 0.56
Most Accurate Estimate 0.54
Earnings ESP -3.57%
Next Earnings Report Date 08-06-2013
EPS Last Year 2.16
Expected Earnings Growth 4.18%

Company Description

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

PFE Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate 0.56 0.54 2.21 2.32
Number of Estimates 6 6 10 8
Low Estimate 0.50 0.53 2.11 2.19
High Estimate 0.58 0.57 2.27 NA
Year Ago EPS 0.62 0.53 2.19 2.21
EPS Growth -10.22% 2.20% 0.87% 4.86%

Average Earnings Estimates for PFE

EPS Growth for PFE

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
PFIZER INC PFE 29.16
NOVO-NORDISK AS NVO 161.70
ABBOTT LABS ABT 36.89
ABBVIE INC ABBV 43.01
ALLERGAN INC AGN 101.48
ASTRAZENECA PLC AZN 50.97
BRISTOL-MYERS BMY 46.44
GLAXOSMITHKLINE GSK 52.74
JOHNSON & JOHNS JNJ 85.63
LILLY ELI & CO LLY 52.36

Sector:Medical>> Industry:LARGE CAP PHARMA

COMPARE TICKER vs. Its Peers

Financials

EPS TTM 2.16
Sales 58,986
Net Income 15,526
Price/Earnings 13.50
Price/Book 2.53
Price/Cash Flow 8.91
Price/Sales 3.59

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.